Search
Search Results
##search.searchResults.foundPlural##
-
-
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
856PDF: 328Html: 53 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2377PDF: 1435Html: 497 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1538PDF: 826HTML: 566 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
3008PDF: 1179HTML: 502Preferred Reviewers: 254 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1889PDF: 572HTML: 365 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3299PDF: 1697HTML: 402 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6515PDF: 2240HTML: 14168Untitled: 254figure: 231 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3916PDF: 1311HTML: 5096Incidence age-standardized rates for HL across the Mediterranean basin: 259 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2017PDF: 1242HTML: 349 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
2772PDF: 911HTML: 3613Diamond Blackfan Anemia: A Tertiary care centre experience: 378 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4776PDF: 2053HTML: 18215 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1198PDF: 1430HTML: 183 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
2013PDF: 819HTML: 255 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3602PDF: 862HTML: 3033Figure 1a and 1b: 201Figure 2: 211Figure 3: 217Figure 4: 209Figure 5: 205Tables 1-5: 185 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2174PDF: 1120HTML: 15744COVER LETTER: 246 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1507PDF: 934HTML: 10112cover letter to the editor: 217tile page: 299 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3463PDF: 1042HTML: 3023 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
2168HTML: 1738PDF: 1210 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2350PDF: 1522HTML: 1000 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2686PDF: 908HTML: 9070Efremov 1: 276Efremov 2: 246 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3048PDF: 1357HTML: 2846Figure 1: 224 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1819PDF: 860HTML: 926jdoe, table 2 infections CML .doc: 253jdoe, table 1 infections CML .doc: 233 -
EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD
1453PDF: 871HTML: 7893Manuscript after revision: 288Barbero10328-36310-after revision: 288 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2361PDF: 1068HTML: 4993 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4676PDF: 1819HTML: 1336







